TopStockTips

Preliminary Results With The Medtainer From The 90 Day Clinical Trials In The Hospice And Palliative Care Industries Are Very Positive

Nutley, NJ -- (ReleaseWire) -- 12/08/2015 --TopStockTips Featured Stock - Acology Inc. (OTCPINK:ACOL) announced that preliminary results from 90 day clinical trials in the hospice and palliative care industries are very positive, with care givers reporting that its signature product, The MedTainer™, provides a perfect platform for patients who have trouble swallowing whole medications. The first set of reports indicates that meds are easily and efficiently ground and administered. Geriatricians, who are increasingly aware of and enthusiastically supporting the use of MedTainers for their patients, are predicting that this unique device will have a serious and wide-reaching niche in the growing, multi-billion dollar home health care market.

In addition, Acology (OTCPINK:ACOL) developers have announced that they believe the MedTainer, as it is currently manufactured and made available nation-wide, has anticipated potential Federal Guidelines for compliant packaging that will be necessary in the medical and recreational marijuana industries. Even though guidelines for the industry have not been set, the fact that The MedTainer is manufactured in the United States from FDA approved #5 polypropylene, as well as being certified child-resistant, smell-proof and water-proof, is merely the start of potential compliance. The product can also be color-coded, properly labeled and potentially micro-chipped for identification and information. The MedTainer is certain to increase in demand as more states approve the use of marijuana in 2016. There is a growing belief that once the tide of approval becomes evident, the Federal Guidelines for packaging will be published. The MedTainer is in a unique position to instantly fill those regulations.

Key Updates From The Company:

-Management declares that the company has progressed in 2015 to the point where more sales associates will be hired to meet the growing demand for the product. It is also projected that by April of 2016 the number of MedTainers distributed within a 30-day cycle will exceeded 75,000 and continue to grow exponentially by mid-summer to 100,000.

-Projected sales at the end of calendar 2015, previously projected conservatively at $1.3M are now expected to surpass $1.5M in gross sales while at the same time reducing costs and increasing margins.

-Acology sales executives had begun to open the geritriac, hospice and palliative care industries and have added 3 distinguished professionals in that field to its Advisory Board. In concert they have introduced Acology to the rapidly-growing medical equipment and skilled-nursing fields and Acology products are now in clinical trials within these industries.

-The original 45 distributors that Acology held in October of 2014 has grown to over 900 domestic and international distributors, wholesalers, merchants and brokers.

-The original physical 5200 sq.ft. sales and distribution center in Corona is expanding an additional 5,000 sq. ft. by the beginning of 2016. New business, in the areas already described but especially in the medical industry, will continue to develop and grow exponentially as demand for the Medtainer increases.

This press release includes statements that are covered by the Private Securities Litigation Reform Act of 1995. Because such statements deal with future events they are subject to risks and uncertainties and actual results for fiscal year 201 and beyond could differ materially from the company's current expectations. Forward-looking statements are identified by such words as "anticipates", "projects", "expects", "planned", "intends" and "believes" "estimate" "targets" and other similar expressions that indicate trends and future events. It is understood that investment entails risk on the part of the investor and could result in the loss of some or all of his or her investment.

Acology Inc. and D&C Distributors are located in their distribution facility at 1620 Commerce St. Corona, California, 92880.

About TopStockTips
TopStockTips is not a registered securities advisor. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides information on highlighted stocks via press releases, newsletters and company website, but this should not be construed as a recommendation to buy or sell. Please visit the company website for a more complete list of risks and disclosures. TopStockTips Inc., Located In Nutley, NJ Is an Investor Relations Firm specializing in all financial markets.